Vitamin B12 Deficiency Treatment Market

Introduction

Vitamin B12, is an important water-soluble vitamin. It mainly helps in nerve tissue health, brain function and red blood cells production. Also, vitamin helps in bone formation, mineralization, and growth. In large surveys in the United States and the United Kingdom, approx. 6% of those aged more than 60 years are Vitamin B12 deficient.

The rate is much high in underdeveloped and developing countries such as Africa, Vienna and some parts of South-East Asia. Vitamin B12 deficiency treatment results majorly due to decreased dietary intake and impaired absorption.

Vitamin B12 deficiency causes balance problems, memory loss, difficulty in thinking, reasoning, anemia etc. The main dietary sources can be meat, egg, salmon, and other dairy products. Apart from that, injectable vitamin B12 formulations are also available in the market like hydroxocobalamin and cyanocobalamin. But treatment with vitamin pills is mostly used as it can be easily incorporated in the regime.

Increasing prevalence of malnutrition among children across the globe is expected to drive the growth of vitamin B12 deficiency treatment market. An estimated 6% of people in the US and UK suffer from vitamin B12 deficiency so there is a vast scope for vitamin B12 deficiency treatment market to grow.

Anemia is one of the major problem in underdeveloped countries which majorly occur due to Vitamin B12 deficiency also, it can help to cure atropic gastritis which occur due to Vitamin B12 deficiency which in turn drive the growth of Vitamin B12 deficiency treatment market. Studies have shown that various food industries can also act as a major puller for vitamin B12 deficiency treatment market.

Many doctors in US and UK are recommending the use of Vitamin B12 oral drugs which also can lead the growth of vitamin B12 deficiency treatment market. Early detection of this deficiency using advanced techniques like ELISA can help the vitamin B12 deficiency treatment market to grow more. The underdeveloped countries lack knowledge and availability for the treatment which can restrict the growth of vitamin B12 deficiency treatment market

Market Segmentation

Based on drug type	Hydroxocobalamin Cyanocobalamin
Based on dosage form	Powder for reconstitution Solution/ Injection Tablets Nasal sprays Syrups
Based on Route	Intravenous Subcutaneous Oral Nasal
Based on distribution channel	Hospital Pharmacy Online sales Retail Pharmacy Drug Stores

Key Players

Some of the profiled key players of vitamin B12 deficiency treatment market that prevalent globally include, Watson Company, Merck and Co. Ltd., Daiichi Sankyo Company, Limited., Dr. Reddy’s Laboratories Ltd., Mylan N.V, Pfizer Inc., Teligent Canada. Other players of vitamin B12 deficiency treatment market include Himalaya Herbal Healthcare, Dabur International Limited.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2014 - 2018
• Market Size & Forecast 2019 to 2029
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales